Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized placebo-controlled trial of 5-aminolevulinic acid in children with autism spectrum disorder
jRCTs051210168Completed
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of aminolevulinic acid in Autism Spectrum Disorder (ASD) (2 arms). Primary endpoint: Stereotypic Behavior score (ABC-J). Started Feb 2022; status: completed.
02
Drugs
aminolevulinic acid
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on jRCTs051210168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051210168.